State to Share in $3 Billion From Drug Company

Tennessee will receive at least $13.5 million as part of one of the largest health care fraud agreements in U.S. history, Attorney General Bob Cooper announced today. GlaxoSmithKline (GSK) has agreed to pay $3 billion to the federal government and participating states nationally to resolve allegations that GSK engaged in various illegal schemes related to the marketing and pricing of drugs it manufactures. GlaxoSmithKline agreed to plead guilty to criminal charges in U.S. District Court for the District of Massachusetts and to pay $1 billion in criminal fines and forfeitures for the illegal marketing and promotion of the drugs Paxil and Wellbutrin. DOJ officials said the company will pay an additional $2 billion to resolve civil allegations under the False Claims Act. The Blog of Legal Times has details

AttachmentSize
glaxosmithkline_070212.pdf172.66 KB